{
    "2021-05-01": [
        [
            {
                "time": "",
                "original_text": "天坛生物(600161)2020年年报及2021年一季报点评：业绩符合市场预期 研发与产能建设积极推进",
                "features": {
                    "keywords": [
                        "天坛生物",
                        "年报",
                        "一季报",
                        "业绩",
                        "市场预期",
                        "研发",
                        "产能建设"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "国联证券5月金股组合",
                "features": {
                    "keywords": [
                        "国联证券",
                        "金股组合",
                        "5月"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}